+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?



Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective?



Digestive Diseases and Sciences 63(8): 2094-2104



The cost-effectiveness of screening and surveillance for Barrett's esophagus continues to evolve as the incidence of esophageal adenocarcinoma increases, biomarkers enhance the identification of individuals at highest risk for developing cancer, and endoscopic eradication of Barrett's esophagus improves. Screening to detect Barrett's esophagus may be cost-effective in selected high-risk groups based on age, race, sex and other factors such as symptoms of heartburn. Currently, endoscopic eradication therapy for Barrett's esophagus and high-grade dysplasia is a cost-effective intervention, while endoscopic therapy for non-dysplastic Barrett's esophagus is not a cost-effective strategy. As diagnosis of low-grade dysplasia improves, endoscopic eradication therapy may also prove to be a cost-effective intervention.

(PDF emailed within 0-6 h: $19.90)

Accession: 065498330

Download citation: RISBibTeXText

PMID: 29948571

DOI: 10.1007/s10620-018-5148-7


Related references

Recommended endoscopic surveillance of patients with Barrett's esophagus (BE) is a cost-effective strategy?. Revista de Gastroenterologia de Mexico 71(1): 46-54, 2006

Summaries for patients. Cost-effectiveness of screening and surveillance for Barrett esophagus. Annals of Internal Medicine 138(3): I-41, 2003

Cost-effectiveness of endoscopic screening followed by surveillance for Barrett's esophagus: a review. Gastroenterology 137(6): 1869-1876, 2009

Is endoscopic surveillance for non-dysplastic Barrett's esophagus cost-effective? Review of economic evaluations. Journal of Gastroenterology and Hepatology 26(2): 247-254, 2011

Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis. Annals of Internal Medicine 138(3): 176-186, 2003

Screening and surveillance of Barrett's oesophagus: what is a cost-effective framework?. Alimentary Pharmacology & Therapeutics 19(Supplement S1): 49-53, 2004

Cost-Effectiveness Analysis on Endoscopic Surveillance Among Western Patients With Barrett's Esophagus for Esophageal Adenocarcinoma Screening. Medicine 94(39): E1105, 2016

Review article: screening and surveillance of Barrett's oesophagus: what is a cost-effective framework?. Alimentary Pharmacology & Therapeutics 19 Suppl 1: 49-53, 2004

Endosheath ultrathin transnasal endoscopy is a cost-effective method for screening for Barrett's esophagus in patients with GERD symptoms. Gastrointestinal Endoscopy 2018, 2018

Endoscopic surveillance of Barrett's esophagus: a cost-effectiveness comparison with mammographic surveillance for breast cancer. American Journal of Gastroenterology 93(6): 911-915, 1998

Motion - Screening and surveillance of Barrett's epithelium is practical and cost effective: arguments against the motion. Canadian Journal of Gastroenterology 16(8): 541-545, 2002

Screening and surveillance for Barrett esophagus. JAMA Internal Medicine 175(2): 159-160, 2015

How far to go? Screening and surveillance in Barrett's esophagus. American Journal of Managed Care 7(1 Suppl): S19-S26, 2001

Screening and surveillance of Barrett's esophagus. Current Gastroenterology Reports 11(3): 195-201, 2009

The cost of surveillance for adenocarcinoma complicating Barrett's esophagus. American Journal of Gastroenterology 83(3): 291-294, 1988